2.0
Mar 26, 2015
Anonymous employee
Former employee, more than 8 years
Recommend
CEO approval
Business Outlook
Pros
Virtual monopoly on Rx data protects market share in core business of pharma sales force effectiveness. Slow pace makes for good work/life balance. Logo has nice range of blue colors.
Cons
IMS is slow to move and reluctant to invest in new technologies which means they are not successful at penetrating new markets. There is a disconnect between strategy and execution which causes morale issues. A move towards off-shoring and driving down wages means top talent is scarce.